Market Access with AWMSG: Your Guide to Wales’ Health Technology Assessment Authority

The All Wales Medicines Strategy Group (AWMSG) advises the Welsh Government on strategic developments in medicines access and management. Established in 2002, AWMSG ensures that patients in Wales receive timely access to effective medicines while promoting their safe and efficient use within NHS Wales.

awttc.nhs.wales

Core Functions of AWMSG

AWMSG’s primary responsibilities include:

•     Evaluating New Medicines: Assessing newly licensed medicines to determine their clinical and cost-effectiveness for use within NHS Wales.
  awttc.nhs.wales
•     Developing Medicines Strategy: Formulating strategies to optimize the use of medicines, ensuring patients derive maximum benefit.
  awttc.nhs.wales
•     Providing Guidance: Issuing advice to healthcare professionals on best practices in prescribing and managing medicines.

Leadership and Key Contacts

As of January 2025, AWMSG is chaired by Professor Iolo Doull, Medical Director of the NHS Wales Joint Commissioning Committee (JCC).

Contact Details for AWMSG

Website: https://awttc.nhs.wales/about-us1/our-committees/#AWMSG

Postal Address:

All Wales Therapeutics & Toxicology Centre
The Routledge Academic Centre
University Hospital Llandough
Penlan Road
Penarth
CF64 2XX

Telephone: +44 (0)2921 826900

Challenges in Working with AWMSG

Engaging with AWMSG involves:

•     Understanding Submission Processes: Familiarity with AWMSG’s procedures for submitting evidence on new medicines is crucial for successful market access.
  awttc.nhs.wales
•     Timely and Accurate Submissions: Ensuring that all necessary documentation is complete and submitted promptly to facilitate evaluation processes.
•     Demonstrating Value for Money: Providing robust evidence that new treatments offer value for money within the NHS Wales framework.
  awttc.nhs.wales

Effective collaboration with AWMSG can lead to efficient market entry and favorable reimbursement outcomes in Wales.

Opportunities / Solutions with Justin Stindt Consultants

Justin Stindt’s AWMSG expertise ensures:

•     Expert Consultant AWMSG Submissions: Creating high-quality submissions for new medicine assessments.
•     Market Access AWMSG Strategies: Developing strategies that align with AWMSG’s evaluation framework to optimize market access.
•     Specialist AWMSG Processes: Providing insights into AWMSG’s procedures to enhance compliance and expedite approvals.

Justin Stindt Consultants specializes in assisting clients to effectively engage with AWMSG’s regulatory environment to achieve successful market access in Wales.